|        About Good Returns  |  Advertise  |  Contact Us  |  Terms & Conditions  |  RSS Feeds

NZ's Financial Adviser News Centre

GR Logo
Last Article Uploaded: Thursday, May 28th, 6:16PM


Latest Headlines

TOWER sales quadruple

TOWER's solution to covering non-Pharmac funded cancer drugs has hit the mark with advisers, with sales of the trauma add-on option to its health insurance quadrupling since key enhancements were introduced in August this year.  

Wednesday, November 17th 2010, 11:41AM

The major overhaul of Premier Health's Serious Condition Lump Sum add-on option included the introduction of a new Cancer Assistance Benefit which pays an additional amount of up to twice the sum insured if a non-Pharmac funded chemotherapy drug, approved by Medsafe, is recommended by a registered specialist for cancer treatment. This payment is over and above the trauma payout.

TOWER Health & Life chief executive Steve Boomert says in introducing cover for non-Pharmac funded drugs it was critical to strike the right balance between giving customers the choice to include the cover and ensuring the base product would not be vulnerable to sustainability issues.

"We are delighted that advisers both value this approach and support it through record sales of the trauma add-on option.

"It clearly indicates that they understand the long-term sustainability concern and the need for commercially sensible solutions," says Boomert.


« Sovereign applying to be a QFEGinger group bursts onto the scene »

Special Offers

Commenting is closed



Printable version  


Email to a friend
Insurance Briefs

Fitch runs Covid-19 ruler over industry
AIA has had its Fitch rating affirmed with a stable outlook, while Suncorp is affirmed with outlook revised to negative.

MDRT waives production requirements
MDRT has waived production requirements for its members this year.

Rating agency gives Partners the tick; Here's what it said
A M Best says Partners Life has a very strong balance sheet and has continued to award its current rating.

Hardship fund for Asteron customers
Suncorp is establishing a $2 million hardship fund for Vero and Asteron Life customers.

News Bites
Latest Comments
Subscribe Now

Cover Notes - Specific news aimed at risk advisers

Previous News


Most Commented On
About Us  |  Advertise  |  Contact Us  |  Terms & Conditions  |  Privacy Policy  |  RSS Feeds  |  Letters  |  Archive  |  Toolbox
Site by Web Developer and